UroGen Pharma's chart data is dated 2026-10-09. There is no active technical signal. There are 9 published signal records.
UroGen Pharma last closed at $36.83 (-0.41%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -19.1×. Its overall grade ranks 3 of 738 stocks in Healthcare.
About this company
UroGen Pharma last closed at $36.83 (-0.41%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 3/738
Valuation grade A-
Related stocks
- Astellas PharmaCustomer
UGN-102 공동개발/상업화 파트너
- Johnson & JohnsonCompetitor
비뇨기암·비뇨기과 치료제 분야 대형 제약 경쟁사
- AstraZenecaCompetitor
비뇨기암 치료 영역에서 경쟁하는 글로벌 제약사
ETFs holding this stock
iShares Micro-Cap ETF
Details →About UroGen Pharma
- What technical signals does UroGen Pharma (URGN) have?
- UroGen Pharma current technical signals: no active technical signal.
- Is UroGen Pharma a cup-and-handle pattern?
- No. UroGen Pharma has no valid Cup signal right now.
- What published figures are available for UroGen Pharma?
- Market cap: $1.72B. Trailing 12 months PER: -19.1×. Latest quarter PBR: -14.07×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about UroGen Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.